Adia Nutrition ADIA
OTC ADIA
$0.12 +0.00 (+0.00%)
At close: Sep 17, 2026 · 4:00 PM EDT

Adia Nutrition (ADIA) Capital Leases (2024 - 2026)

Adia Nutrition's (ADIA) quarterly Capital Leases came in at $55586.0 in Q1 2026, down 9.45% quarter-over-quarter from $61387.0 in Q4 2025.

Analysis

Adia Nutrition (ADIA) Capital Leases (2024 - 2026) Analysis & Trends

Adia Nutrition (ADIA) has reported Capital Leases for 3 consecutive years, with $55586.0 the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Capital Leases changed N/A year-over-year to $55586.0 in Q1 2026; TTM through Mar 2026 was $55586.0, a N/A change from a year earlier, with the FY2025 full-year figure at $61387.0, down 30.27% from the prior year.
  • Capital Leases was $55586.0 for Q1 2026 at Adia Nutrition, down from $61387.0 in the prior quarter.
  • Over five years, Capital Leases peaked at $88030.0 in Q4 2024 and troughed at $55586.0 in Q1 2026.
  • A 3-year average of $68334.3 and a median of $61387.0 in 2025 frame the typical range for Capital Leases.
  • The widest YoY moves for Capital Leases: up 30.27% in 2025, down 30.27% in 2025.
  • Over 3 years, Capital Leases stood at $88030.0 in 2024, then slumped by 30.27% to $61387.0 in 2025, then declined by 9.45% to $55586.0 in 2026.
  • The last three Capital Leases figures came in at $55586.0 (Q1 2026), $61387.0 (Q4 2025), and $88030.0 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 9.96 Bn 9.12 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.47 Bn 5.47 Bn -
3 Iovance Biotherapeutics 4.64 Bn 4.35 Bn 55.72 Mn
4 Legend Biotech 3.25 Bn 2.28 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Precigen 2.79 Bn 2.79 Bn 52.17 Mn
7 Beam Therapeutics 2.58 Bn 2.58 Bn -
8 Sarepta Therapeutics 2.12 Bn 1.33 Bn 251.87 Mn
9 Vericel 2.05 Bn 1.89 Bn 56.40 Mn
10 Adia Nutrition 11.33 Mn 11.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 55,586.00
Dec 31, 2025 61,387.00
Dec 31, 2024 88,030.00